missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human Spectrin beta-5 (aa 3581-3656) Control Fragment Recombinant Protein
Click to view available options
Cantidad:
100 μL
Tamaño de la unidad:
100 microlitros
Descripción
Highest antigen sequence indentity to the following orthologs: Mouse (32%), Rat (32%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-140081 (PA5-140081. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
SPTBN5 (Spectrin Beta, Non-Erythrocytic 5) is a Protein Coding gene. Diseases associated with SPTBN5 include Epileptic Encephalopathy, Early Infantile, 5 and Spinocerebellar Ataxia 5. Among its related pathways are RET signaling and Signaling by GPCR. Gene Ontology (GO) annotations related to this gene include actin binding and kinesin binding. An important paralog of this gene is DST. [GeneCards]

Especificaciones
Especificaciones
Número de acceso | Q9NRC6 |
Concentración | ≥5.0 mg/mL |
Para utilizar con (aplicación) | Blocking Assay, Control |
Formulación | 1 M urea, PBS with no preservative; pH 7.4 |
ID de gen (Entrez) | 51332 |
Nombre | Human Spectrin beta-5 (aa 3581-3656) Control Fragment |
Cantidad | 100 μL |
Estado normativo | RUO |
Alias de gen | beta V spectrin; beta-V spectrin; BSPECV; HU HUSPECV; HUBSPECV; HUSPECV; spectrin beta chain, brain 4; spectrin beta chain, non-erythrocytic 5; spectrin beta, non-erythrocytic 5; spectrin, beta, non-erythrocytic 5; spectrin, non-erythroid beta chain 4; SPTBN5 |
Nombre común | SPTBN5 |
Mostrar más |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
Invitrogen™ Human Spectrin beta-5 (aa 3581-3656) Control Fragment Recombinant Protein >
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido